Dennis Podlesak Net Worth & Insider Trades

Dennis Podlesak Syndax Pharmaceuticals Inc

As of February 3, 2023

What is Dennis Podlesak's Net Worth?

The current estimated net worth of Syndax Pharmaceuticals Inc's Dennis Podlesak is estimated to be about $2.67M . Dennis Podlesak owns about 75,763 units of Syndax Pharmaceuticals Inc common stock. In the last 7 years at Syndax Pharmaceuticals Inc, Dennis Podlesak has sold an estimated value of $1.9M worth.

What is Dennis Podlesak's Past Insider Trading?

Dennis Podlesak's largest purchase order was 78,815 units , worth over $498.31K on September 16, 2022. Dennis Podlesak's largest sale order was 78,815 units , worth over $1.9M on September 16, 2022. In total, Dennis Podlesak has made about 12 transactions over 7 years of their time at Syndax Pharmaceuticals Inc. Dennis Podlesak usually trades in February, with the busiest year in 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dennis Podlesak

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Dennis Podlesak's' Mailing Address?

  • Mailing address is C/o Peninsula Pharmaceuticals, Inc. 1751 Harbor Bay Parkway Alameda CA 94502 CA

What are Syndax Pharmaceuticals Inc's Past Insider Trades?

Syndax Pharmaceuticals Inc's most recent insider trade came on August 10, 2023 by Briggs Morrison who sold 52,855 units worth $965.4K . In the last 7 years, insiders at Syndax Pharmaceuticals Inc have sold an estimated value of $49.58M and bought an estimated value of $19.68M worth of shares. Insider trading is most common in February, with the busiest year in 2021 and 2022. The most active traders at the company are Briggs Morrison,  Michael A Metzger, Chief Executive Officer,  and Peter Ordentlich, Chief Scientific Officer .

Syndax Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...